Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

SpeedWeed

AUGUST 11, 2021

Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression, and PTSD,” said Sisley in a press statement. MAPS Makes History. Results of this study showed evidence of the pros and cons to cannabis as a treatment for PTSD patients.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

FEBRUARY 28, 2022

Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Controlled Substance Schedules , DRUG ENF’T ADMIN., [link] [ [link] ] (defining DEA criteria for categorization in Schedule I and listing psychedelic examples such as lysergic acid diethylamide (LSD), peyote, and MDMA).

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Canna Law Blog

OCTOBER 1, 2020

This post examines the history of religious exemptions to the CSA. According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. DEA Interim Guidelines.

History 98

History Law DEA Safety 98

MedicalJane

JUNE 29, 2018

Doctors may not prescribe cannabis products to patients because marijuana is currently listed as an example of a Schedule I drug according to the DEA. Some doctors are hesitant to recommend cannabis as a treatment claiming there is limited research – which has been held back by federal law.

Patients 83

Patients Legalization Conditions Treatment 83

Cannabis Law Report

JUNE 15, 2021

Reinvests funds to support programs that work on expanding access to substance use treatment, support harm reduction services, and reduce the criminalization of individuals who use drugs by supporting the development or expansion of pre-arrest diversion programs. Promotes evidence-based drug education.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

The Cannigma

JULY 3, 2023

Canada and Australia have already passed legislation allowing for MDMA use for mental health treatment. And simultaneously, legislators around the world are considering legalizing MDMA for medicinal use, including the FDA. 8 9 Related Stories What’s the deal with ketamine?

Research and Development 46

Research and Development Environment THC Microdosing 46

Canna Law Blog

OCTOBER 23, 2020

Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. Per the usual course, the DEA filed a motion to dismiss for failure to exhaust administrative remedies.

DEA 70

DEA Policy History Treatment 70

Cannabis Law Report

APRIL 14, 2022

pursuant to Drug Enforcement Agency (DEA) or state-level programs). These facilities can also take a toll on water treatment facilities that were not designed for (and do not monitor for) cannabis waste products, fertilizers, and pesticides.

Environment 52

Environment Agriculture Compliance Compliance 52

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. Patients Are Not In This Alone.

Therapy 53

Therapy DEA Patients Clinical Trials 53

Cannabis Law Report

JULY 30, 2021

The CAOA transfers regulation of cannabis from the Drug Enforcement Agency (DEA) to the FDA, the TTB and the Bureau of Alcohol, Tobacco, Firearms & Explosives (ATF) within the Department of Justice—giving the agencies similar regulatory and enforcement authority as they have with alcohol and tobacco.

Hemp 105

Hemp Law Seed-To-Sale Food 105

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. They also wrote: The study sample included participants with a history of cannabis use.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Canna Law Blog

OCTOBER 29, 2019

Applicants must submit their contact information and a criminal history report. As such, the regulatory definition of “acceptable hemp THC level” describes how State, Tribal, and USDA plans must account for uncertainty in test results in their treatment of cannabis. Interstate Transport.

Hemp 66

Hemp THC Compliance Compliance 66

Cannabis Law Report

MAY 24, 2022

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. To consider the full impact of this Supreme Court decision it is necessary to delve into the history of the Controlled Substance Act.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

SEPTEMBER 12, 2021

There’s an FDA approved synthetic THC drug that is legal and accessible for the treatment of some types of nausea (Marinol), but it’s not popular, and there are often reports of side effects that are not typically seen with whole plant cannabis. Is THC legal in the US? THC and the entourage effect. Medicinal properties and benefits of THC.

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

MARCH 21, 2019

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. Schedule 1 drugs are substances, chemicals, or drugs considered by the federal government to have no medical use and a high potential for abuse such as heroin, LSD, and ecstasy.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Info

MARCH 26, 2019

There was even a time in history for over 200 years when you could pay your taxes in America with hemp. In the mid 1930s, the M-word was created to tarnish the good image and phenomenal history of the hemp plant…as you will read. Realize the history that created it. seconds someone in the world dies of hunger. Get together.

Marijuana 51

Marijuana Hemp Blood Pressure Oil 51

SpeedWeed

DECEMBER 28, 2018

On October 17, Canada made history by becoming the second nation (after Uruguay) to federally legalize adult-use cannabis. Because here’s the recipe, which includes nothing expensive: EPIDIOLEX (cannabidiol) oral solution is a clear, colorless to yellow liquid containing cannabidiol at a concentration of 100 mg/mL.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 30, 2019

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. That a patient had exhausted all other “recognized traditional treatment options available for condition” before turning to medical cannabis as a therapeutic medicinal treatment. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 14, 2021

These efforts are not mutually exclusive, and history has shown that when it comes to cannabis, every step in the right direction builds momentum for bigger and better reforms at the state and national level.”. A recent study by The Initiative reported that access to capital was the top concern of social equity cannabis operators.

Legislation 71

Legislation Banking History Access 71